U.S. Biliary Stents Market by Type (Metal Biliary stents, and Plastic Biliary stents), Application (Malignant Obstruction, Benign Biliary Strictures, Biliary Leaks, and Others), and End User (Hospitals, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3423
- Pages: 100
-
Format:
The U.S. biliary stents market was valued at $316 million in 2017 and is expected to reach $474 million by 2025, growing at a CAGR of 5.2% from 2018 to 2025. A biliary metal stent also known as a bile duct stent is a flexible metallic tube specifically designed to open a patients bile duct that has been blocked or partially blocked. A biliary stent is inserted to reduce or eliminate the blockage. Once it is in place in the obstructed part, the stent expands and opens the channel so that fluids can continue to move to the intestine. Metallic stents are generally made with cobalt-chromium (stainless steel) or an alloy, including nickel-titanium (nitinol), which is a shape memory alloy.
The significant rise in the prevalence of pancreatic cancer and other biliary diseases across the U.S. is one of the major factors that drives the biliary stents market. For instance, according to the American Cancer Society (2019), pancreatic cancer accounts for about 3% of all cancers in the U.S. and about 7% of all cancer deaths. In addition, technological advancements associated with biliary stents and surge in demand for minimally invasive procedures further contributes to the market growth.
Although the U.S. biliary stents market continues to grow, certain factors hamper the growth of this market. The complications and high costs associated with biliary stents are anticipated to hamper the market growth. Conversely, development of innovative smartphone applications leading to better adoption and opportunities in the emerging economies are anticipated to offer growth opportunities for the U.S. biliary stents market.
The U.S. biliary stent market is segmented based on type, application, and end user. Based on type, it is categorized into biliary metal stents, and biliary plastic stents. Based on application, the market is categorized into malignant obstruction, benign biliary strictures, biliary leaks, and others. Based on end user, it is divided into hospitals and ambulatory surgical centers. The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Conmed Corporation, Cook Medical, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Merit Medical, Olympus Corporation, and Becton, Dickinson and Company. The other players included in the value chain analysis (but not included in the report) are Taewoong Medical Co., Ltd., Biosensors International Group, Ltd., and others.
Key Benefits for Stakeholders
The report provides an extensive analysis of the current market trends and future estimations of the U.S. biliary stents market.
The U.S. biliary stents market top player positioning is comprehensively analyzed in the report.
The U.S. biliary stents market share is comprehensively analyzed with respect to the application, type, and end user.
U.S. biliary market growth analysis by type helps understand the significance of the different types of biliary stents available in the market.
Key manufacturers involved in the U.S. biliary stents market are listed and analyzed in this report to understand the competitive scenario of the market.
Key Market Segments
By Type
o Metal biliary stents
o Plastic biliary stents
By Application
o Malignant obstruction
o Benign biliary strictures
o Biliary leaks
o Others
By End User
o Hospitals
o Ambulatory surgical centers
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of biliary diseases
3.5.1.2. Technological advancements associated with biliary stents and urge in demand for minimally invasive procedures
3.5.2. Restraint
3.5.2.1. Complications and high costs associated with biliary stents
3.5.3. Opportunity
3.5.3.1. Development of innovative smartphone applications
Chapter: 4: U.S. BILIARY STENTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Metal Biliary Stents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Plastic Biliary Stents
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
Chapter: 5: U.S. BILIARY STENTS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Malignant obstruction
5.2.1. Market size and forecast
5.3. Benign biliary strictures
5.3.1. Market size and forecast
5.4. Biliary leaks
5.4.1. Market size and forecast
5.5. Others
5.5.1. Market size and forecast
Chapter: 6: U.S. BILIARY STENTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.3. Ambulatory surgical centers
6.3.1. Market size and forecast
Chapter: 7: COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BECTON, DICKINSON AND COMPANY
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. BOSTON SCIENTIFIC CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. COOK MEDICAL INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.6. CONMED CORPORATION
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Product portfolio
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. MERIT MEDICAL SYSTEMS, INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. OLYMPUS CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. TERUMO MEDICAL CORPORATION
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
